MPDL3208A

Where Is Biotechnology's Next 'Anti-PD-1'?
Seeking Alpha
Tue, 06/18/13 - 09:50 am
anti-PD-1 immunotherapy
Dendreon
Merck
Bristol-Myers Squibb
Baxter International
Yervoy
Provenge
lambrolizumab
MPDL3208A